Grote I, Bartels S, Christgen H, Radner M, et al. ERBB2 mutation is associated with sustained tumor cell proliferation after short-term preoperative endocrine therapy in early lobular breast cancer. Mod Pathol 2022 Jul 16. pii: 10.1038/s41379-022-01130.
PMID: 35842479